The AGA Research Foundation Provides over $2 million in Funding to Promising Researchers

The American Gastroenterological Association (AGA) is excited to announce the 17 researchers selected to receive funding through the AGA Research Foundation Awards Program. The 2020 award year will provide $2.2 million in research funding to support outstanding investigators working on projects that will enhance our understanding of gastrointestinal and liver conditions and ultimately lead to better treatment options for patients with digestive disorders.

“This year’s selected awardees are committed to transforming the gastroenterology field with their research projects that span the entire digestive tract,” said Robert S. Sandler, MD, MPH, AGAF, chair, AGA Research Foundation. “We are excited to continue the foundation’s tradition of excellence with the support of many gifted early career researchers and look forward to seeing how their research evolves with this funding.”

Of the 2020 class of awardees, half are female and 12% are from racial or ethnic groups traditionally underrepresented in biomedical research. In line with the AGA Research Foundation’s mission to support the next generation of researchers in digestive diseases, 71% of the 2020 awardees are early-career investigators. Approximately one-third are performing clinical research.

RESEARCH SCHOLAR AWARDS

AGA Research Scholar Award 

  • Andrea Geisz, PhD, Boston University Henry M. Goldman School of Dental Medicine, Massachusetts
  • Haifa Mtaweh, MD, The Hospital for Sick Children, Toronto, Canada
  • Long H. Nguyen, MD, MS, Massachusetts General Hospital and Harvard Medical School, Boston
  • Shuang Wang, PhD, Icahn School of Medicine at Mount Sinai, New York City

AGA-Gastric Cancer Foundation Ben Feinstein Memorial Research Scholar Award in Gastric Cancer 

  • Samuel J. Klempner, MD, Massachusetts General Hospital, Boston

AGA-Takeda Pharmaceuticals Research Scholar Award in Inflammatory Bowel Disease 

  • José Ordovas-Montañes, PhD, Boston Children’s Hospital, Massachusetts

SPECIALTY AWARDS

AGA-Caroline Craig Augustyn & Damian Augustyn Award in Digestive Cancer 

  • Peter S. Liang, MD, MPH, New York University Langone Health, New York City

AGA-R. Robert & Sally Funderburg Research Award in Gastric Cancer 

  • Ajay Goel, PhD, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Monrovia, California

 

PILOT AWARDS

AGA-Allergan Foundation Pilot Research Award in Inflammatory Bowel Disease 

  • Chun-Jun Guo, PhD, Weill Cornell Medicine, New York City

AGA-Allergan Foundation Pilot Research Award in Nonalcoholic Fatty Liver Disease 

  • Jun Wu, PhD, University of Michigan, Ann Arbor

AGA-Elsevier Pilot Research Award 

  • Hien Dang, PhD, Thomas Jefferson University, Philadelphia, Pennsylvania
  • Tirthadipa Pradhan-Sundd, PhD, University of Pittsburgh, Pennsylvania

AGA-Pfizer Young Investigator Pilot Research Award in Inflammatory Bowel Disease 

  • Mallory Chavannes, MD, MHSc, Children’s Hospital Los Angeles, California
  • Trevor M. Darby, PhD, MS, Emory University, Atlanta, Georgia
  • Michael Howitt, PhD, Stanford University School of Medicine, California

AGA-Rome Foundation Functional Gastrointestinal and Motility Disorders Pilot Research Award 

  • Nitin Kumar Ahuja, MD, MS, University of Pennsylvania, Philadelphia
  • Bindu Chandrasekharan, PhD, Emory University, Atlanta, Georgia

 

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”